Asymchem Boston is a CDMO focusing on providing early-stage R&D service to emerging biopharma companies. Solutions we offer include development of a synthetic chemical process, pre-formulation study and formulation development for small molecules, peptides, and oligonucleotides. Our expertise lies in early stage process development for both DS and DP and we can support production from IND to first-in-human study.
